Following individuals through the cascade of care, from HIV diagnosis to treatment and undetectable viral load, rather than taking snapshots of performance, has led researchers on a major South African study to pinpoint linkage to care after testing HIV positive as the biggest weakness of ...

Researchers recently published their findings on a combination therapy for use in patients with hepatitis C (HCV) genotype 4 in PLoS One. According to the Belgian researchers, sofosbuvir in combination with simeprevir with or without ribarivirn was found to be safe and effective. According to the ...

Acting Deputy Chief of Mission of the United States to Tajikistan Lucy Jilka yesterday (January 31) joined the First Deputy Minister of Health and Social Protection of Population of Tajikistan Saida Umarzoda, national health leadership, physicians, TB doctors, and stakeholders to celebrate the introduction of ...

Fast-track the end of AIDS in the EU – practical evidence-based interventions In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discuss how to reverse this trend and ...

Only a minority of centres have specialist clinics for management of co-morbidities Two-thirds of HIV clinics in the UK do not think there is a current need for specialist care services targeted at older adults, investigators report in HIV Medicine. “This is important as, although there ...

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it received written communication from the U.S. Food and Drug Administration (FDA) that the clinical development program for RG-101 remains on clinical hold. In ...

On December 14 2016, the closing EUPATI workshop named “All Aboard to a Better Health Future” took place in Brussels. The meeting presented the achievements, learnings, goals, work done, accomplishments, as well as plans for the future sustainability and continuation of the EUPATI toolbox, trainings, ...

The National Institute for Health and Care Excellence has now published final guidance endorsing Epclusa as an option for the treatment of adults with chronic hepatitis C genotype 1-6 infection on the NHS in England and Wales. Epclusa – a once-daily, fixed-dose combination of the nucleotide ...

Currently most effective directly-acting antiviral agent for hepatitis C (HCV) treatment has already arrived to Ukraine! Alliance for Public Health launches the third phase of HCV treatment program for key populations. This phase stipulates using a direct-acting antiviral agent, which is new for Ukraine – Harvoni ...

Study finds good nutrition improves medication adherence and mental health HIV-positive people who received healthy food and snacks for six months were more likely to adhere to their medication regimens, and they, as well as people with type 2 diabetes, were less depressed and less likely ...

In an effort to improve the international response to combatting multidrug-resistant TB, MPP and Johns Hopkins University sign licensing agreement for investigational treatment sutezolid Geneva, 25 January 2017 — The Medicines Patent Pool today announced that it has signed a licence with Johns Hopkins University ...

The Russian Health Ministry has abandoned a proposal to allocate additional funding to the fight against the spread of HIV. According to the RBC news agency, the ministry submitted a four-year plan to the federal government this week that does not include a proposal to ...

Around one in six young and middle-aged HIV-positive men doing well on antiretroviral therapy (ART) had low testosterone levels, French investigators report in the online edition of AIDS. Overall, 12% of the sample had low testosterone, or male hypogonadism. Risk factors were longer duration of ...

A group of researchers is investigating whether or not interferon-free therapy could reverse the cognitive declines that appear to accompany infection with the hepatitis C virus (HCV), with or HIV coinfection. Felix Kleefeld, of Berlin, Germany, and colleagues examined how eradicating HCV affected the cognition of ...

Initiating, rather than deferring, antiretroviral therapy (ART) reduces the risk of severe bacterial infections in HIV-positive individuals with high CD4 counts, researchers say. Their data are from the START trial, which showed a 57% reduction in the risk of AIDS and non-AIDS morbidity and mortality in ...

A pioneering new clinical trial aiming to find a radically improved course of treatment for drug-resistant tuberculosis (TB) began on 17th January 2017, when the first patient took the first pill in Uzbekistan. The phase II/III trial, called TB PRACTECAL, aims to find a treatment regime ...

For the first time in the United States, a 31-year-old male with primary sclerosing cholangitis received a liver transplant from a deceased donor infected with hepatitis C virus (HCV). Primary sclerosis cholangitis slowly damages the bile ducts in the liver. After Lorenzo Swank learned his liver ...

Health Ministry says 824,000 of the estimated 850,000 HIV-positive people in Russia have already been added to the registry/ The Russian government has abandoned plans to fine HIV-infected patients who refuse to register on a Kremlin-administered list of sufferers. Patients would have been forced to add their name ...